TheraRadar
← Back
Data updated: Mar 29, 2026

LEO PHARM

DermatologyImmunologyOncology
Pharma

LEO PHARM is a pharmaceutical company focused on Dermatology, Immunology, Oncology. Key products include PICATO.

1989
Since
3
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 69%
0 drugs Phase 3: 17 Phase 2: 14 Phase 1: 11
Immunology 29%
0 drugs Phase 3: 6 Phase 2: 4 Phase 1: 13
Oncology 3%
0 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...